SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-037675
Filing Date
2022-12-05
Accepted
2022-12-05 17:42:30
Documents
2
Period of Report
2022-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1639
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4576
  Complete submission text file 0000899243-22-037675.txt   7737
Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Howton David T (Reporting) CIK: 0001529297 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 221446043

Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Issuer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)